DREAM started countering AIDS in Africa in 2002. A program aimed at making possible and accessible not only antiretroviral therapy, but also the whole complex of measures and factors which could make it effective: health education, nutritional support, advanced diagnostics, staff training, fighting malaria, tuberculosis, opportunistic infections and especially malnutrition.
The practice of prevention itself was made effective through the therapy. Today, there is no longer fear of the test or the anguish of knowing that, before, it represented a declaration of early death: knowledge becomes protection to the patients themselves as well as to others.
When we first started to take the first steps, the dream of bringing the treatment of AIDS in Africa was considered by many to be a utopia, a beautiful project, ambitious but unachievable. Over the years the global interest and funding in the fight against the disease have led to a better chance of diagnosis and treatment in many areas of the world including Africa and the development of new groups of drugs. Today, after more than a decade, thanks to the intervention of DREAM, it is now possible to prevent and treat HIV / AIDS in all African countries.
All are amazed by the impressive success of the program, its rapid spread in Africa and the influence exerted on Governments and international Agencies to alter attitudes towards antiretroviral therapies. Indeed, the results and products achieved have played a role in the World Health Organization by reshaping the therapeutic protocols for Africa.
The effectiveness of the program has been substantiated in the practical application of therapeutic-diagnostic protocols used in the Western world, in Africa with African patients and professionals, many of them trained during the many courses which are held regularly in those countries where DREAM is present.
It can be said that a large part of the success is due to the original DREAM interpenetration of the scientific component of the academic and practical application.
Measure of this success is the high degree of retention that is recorded in our program.
Today it is known to all that the therapy has an important preventive component due to its ability to reduce viral load in plasma and in all body fluids, decreasing infectivity. Today our frontier to win the battle against AIDS is Universal Access to treatment, namely treating all AIDS patients to eradicate the disease in the whole population of the continent.